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The integration of viral cDNA into the host genome
is a critical step in the life cycle of HIV-1. This step is
catalyzed by integrase (IN), a viral enzyme that is
positively regulated by acetylation via the cellular
histone acetyl transferase (HAT) p300. To investigate
the relevance of IN acetylation, we searched for
cellular proteins that selectively bind acetylated IN
and identified KAP1, a protein belonging to the
TRIM family of antiviral proteins. KAP1 binds acety-
lated IN and induces its deacetylation through
the formation of a protein complex which includes
the deacetylase HDAC1. Modulation of intracellular
KAP1 levels in different cell types including T cells,
the primary HIV-1 target, revealed that KAP1 curtails
viral infectivity by selectively affecting HIV-1 integra-
tion. This study identifies KAP1 as a cellular factor
restricting HIV-1 infection and underscores the rele-
vance of IN acetylation as a crucial step in the viral
infectious cycle.
INTRODUCTION
A key step in retroviral life cycle is the integration of the double-
stranded viral cDNA into the host cellular genome, a reaction
catalyzed by the viral integrase (IN) protein (Vandegraaff and
Engelman, 2007).
The double-stranded DNA molecule is reverse transcribed
from the viral RNA genome soon after virion entry into the cyto-
plasm. The DNA ends of the neosynthesized viral genome are
processed by IN, producing recessed 30 OH termini at each
end of the linear molecule (Vandegraaff and Engelman, 2007).
The recessed 30 ends are then used in a nucleophylic attack on
the host DNA to covalently join the viral and the host genomes
(Vandegraaff and Engelman, 2007). The terminal cleavage and
the strand transfer steps can be modeled in vitro with purified
IN (Vandegraaff and Engelman, 2007). Nevertheless, in cells inte-
gration occurs within a large nucleoprotein complex termed the
preintegration complex (PIC), which is formed by the viral cDNA,
viral proteins, and numerous cellular factors playing important484 Cell Host & Microbe 9, 484–495, June 16, 2011 ª2011 Elsevier Inregulatory roles (Suzuki and Craigie, 2007; Van Maele et al.,
2006; Vandegraaff and Engelman, 2007). One of the cellular
factors exploited by HIV-1 during the integration process is the
histone acetyl transferase (HAT) p300, which specifically acety-
lates the carboxyl terminus of IN (Cereseto et al., 2005). We
have previously reported that acetylation of IN lysines 264,
266, and 273 increases catalytic activity of this enzyme and
that their mutation (K264, 266, 273R) significantly impairs viral
replication (Cereseto et al., 2005; Terreni et al., 2010). Since
posttranslational modifications, like acetylation, dynamically
change the chemical and structural properties of proteins gener-
ating new protein-protein interfaces, we wanted to search for
possible cellular partners selectively interacting with acetylated
IN. Although most IN-interacting factors were identified through
the yeast two-hybrid approach (Van Maele et al., 2006), conven-
tional two-hybrid screening, however, does not allow identifica-
tion of factors that bind specifically to acetylated baits. We
therefore developed a tethered catalysis two-hybrid system in
which constitutively acetylated IN is used as bait. The tethered
catalysis system exploits the cis enzymatic activity of a HAT
domain, which determines constitutive acetylation of the
substrate to which it is fused. From this screening, KAP1 (also
known as TRIM28 or Tif-1 b) has emerged as a factor that inter-
acts specifically with acetylated IN. KAP1 was initially identified
as a transcriptional corepressor that is recruited to its target
genes by interacting with the Kruppel-associated box-domain-
containing (KRAB) zinc-finger DNA proteins (Friedman et al.,
1996; Peng et al., 2000). KAP1 mediates gene silencing (Ivanov
et al., 2007; Sripathy et al., 2006) by recruiting on target
promoters the NuRD histone deacetylase (HDAC) complex
(Schultz et al., 2001), the histone methyltransferase SETDB1
(Schultz et al., 2002), and the heterochromatin-associated
protein HP-1 (Lechner et al., 2000). KAP1 belongs to the tripartite
motif (TRIM) protein family which displays antiviral properties,
targeting retroviruses in particular (Nisole et al., 2005). Impor-
tantly, KAP1 has been recently reported to restrict a gamma-
retrovirus, M-MLV, in embryonic cells by silencing the proviral
transcription (Wolf and Goff, 2007). Mounting evidence now
suggests that KAP1, in addition to its documented transcrip-
tional corepressor activity, is involved more broadly in various
nuclear functions (e.g., DNA damage response) (White et al.,
2006; Ziv et al., 2006).
KAP1 acts by forming protein complexes containing HDACs
leading to the reversible acetylation of nonhistone proteinsc.
Figure 1. Identification of KAP1 in Yeast
Two-Hybrid Screen Using Constitutively
Acetylated Integrase as a Bait
(A) Schematic representation of IN-HATw (left) and
IN-HATm (right) chimeras. IN codon optimized is
fused to the p300 HAT domain either wild-type
(HATw) or mutated (HATm). Between the IN and
the HAT domains, a TEV protease cleavage site is
inserted to allow separation of the two domains.
(B) IN-HATw and IN-HATm fusion recombinant
proteins undigested (TEV) or TEV digested
(+TEV) were immunoblotted with anti-acetylated
IN-specific antibodies (aAcIN) (left panel). The
immunoblot was reprobed with aIN antibodies for
total IN (right panel).
(C) The IN-HATw and IN-HATm chimeras ex-
pressed in yeast cells (AH109) were immunopre-
cipitated with aHA antibodies and immunoblotted
with aAcIN antibodies to detect acetylated IN.
Total IN was detected with aIN antibodies.
(D) Interaction efficiencies of the IN-HATw and IN-
HATm chimeras and single domains (HAT, IN, and
GDBD) with KAP1 in yeast two-hybrid assay.
See also Figure S1.
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Wang et al., 2005, 2007). As acetylation is a dynamic regulatory
mechanism that involves the deacetylation activity of the HDAC
protein family, in this study accordingly we analyzed the dynamic
mechanisms regulating the acetylation levels of IN through
KAP1. In particular, we examined whether that KAP1-mediated
inhibition of viral integration may represent a cellular defense
mechanism against viral infection.
RESULTS
Two-Hybrid Screening with Acetylated IN
To identify cellular factors binding specifically to acetylated IN,
we have performed a tethered catalysis two-hybrid screening
in which IN used as bait is constitutively acetylated. To this
aim, a chimera in which IN is fused to the HAT domain of p300
(IN-HATw) (Figure 1A, left panel) was engineered. To allow the
separation of IN from the HAT domain, a proteolytic cleavage
site for TEV was introduced between IN and HAT. As control,
the same chimera was constructed containing a catalytically
inactive HAT domain (IN-HATm) (Figure 1A, right panel).
The IN-HAT chimeras were purified from bacteria and verified
for acetylation by western blot using antibodies specific for acet-
ylated IN. Figure 1B, left panel, shows a highmolecular size bandCell Host & Microbe 9, 484–4corresponding to the full-length IN-HATw
chimera, while no signal was detected in
the IN-HATm control. The TEV-digested
products of both chimeras were also
analyzed using antibodies against acety-
lated IN. IN-HATw showed a band at the
same size of IN, while no signal could be
detected from the cleavage of IN-HATm
(Figure 1B, right panel), thus indicating
that IN is indeed acetylated within the
IN-HATw chimera.In addition, specific acetylation of lysines 264, 266, and 273,
formerly identified by site-directed mutagenesis (Cereseto
et al., 2005), was verified by mass spectrometry analysis of the
IN-HATw chimera (see Figure S1 available online). To perform
the two-hybrid screen, IN-HATw and IN-HATmwere then cloned
in a yeast expression vector (PBD-Gal4) in-framewith GAL4DNA
binding domain (GDBD) at the N terminus and a HA tag at the C
terminus. Following transformation of yeast cells, the level of IN
expression and acetylation was checked by immunoblot anal-
ysis showing specific acetylation only in the GDBD-IN-HATw
sample (Figure 1C, upper panel).
The vector expressing the GDBD-IN-HATw chimera was then
cotransformed in yeast cells (AH109) with a human lymphocyte
cDNA library cloned in a yeast expression vector (pACT) fused
to GAl4 activation domain (GAD). The AH109 reporter strain
carries ADE2, HIS3, lacZ, and MEL1 genes. From the two-hybrid
selective medium (Ade, His) we obtained 754 positive clones
(Ade+, His+) encoding for 13 factors. Three clones encoded for
the same domain (aa 304–835) of the KAP1 gene (HSU78773).
KAP1 has drawn our attention because it was recently reported
to restrict M-MLV in embryonic stem cells (ESCs) (Wolf and Goff,
2007), and so is potentially involved in HIV-1 biology.
To test the specificity of interaction between KAP1 and
acetylated IN, a comparative analysis was performed by95, June 16, 2011 ª2011 Elsevier Inc. 485
Figure 2. KAP1 Preferentially Binds Acety-
lated IN Rather Than the Unmodified Form
In Vivo and In Vitro
(A) HEK293T cell lysates expressing Flag-KAP1
were incubated with the IN-HATw or IN-HATm
chimeras (left panel) and with IN isolated from
the IN-HATw (IN-Ac+) or from IN-HATm (IN-Ac)
by TEV digestion (right panel). The aFlag im-
munocomplexes were blotted with aHA anti-
bodies to detect bound IN-HAT chimeras and
reprobed with aFlag antibodies to check for KAP1
expression.
(B) HEK293T cells expressing either Flag-IN wild-
type (Flag-INw) or mutated at acetylable lysines
(K264, 266, 273R) (Flag-INm) were immunopre-
cipitated with aFlag antibodies and blotted using
a-KAP1 antibodies.
(C) In vitro binding between 35S-KAP1 and IN-
HATw or IN-HATm recombinant proteins. The
graph expresses the amounts of KAP1-bound
protein as percentages of the binding reaction
35S-KAP1 + IN-HATw.
(D) In vitro binding between 35S-KAP1 and re-
combinant full-length IN fused to GST (GST-IN) or
each single recombinant IN domain fused to GST:
N terminus (GST-IN-Nt), catalytic (GST-IN-Cat),
and C terminus (GST-Ct). The graph expresses the
amounts of KAP1-bound protein as percentages
of input (35S-KAP1). In (C) and (D), the upper
panels show the gels exposed to Phosphoimaging
(Cyclone) and the lower panels the Coomassie
staining of the SDS-PAGE gels.
See also Figure S2A.
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fusion proteins: IN-HATw, IN-HATm, HATw, HATm, or Gal4-BD
alone. These two-hybrid analyses showed that KAP1 interacts
more efficiently with the acetylated IN (IN-HATw) than the
unmodified IN (IN-HATm and IN), and no interaction was
detected between KAP1 and the individual single domains
(HATw, HATm, and Gal4-BD) (Figure 1D). These results indicate
that KAP1-IN interaction is highly favored by IN acetylation
catalyzed by p300.
Interaction between Acetylated IN and KAP1
To validate the interaction between the acetylated IN and KAP1,
the binding of the two proteinswas further analyzed in amamma-
lian system. KAP1 fused to a Flag tagwas expressed in HEK293T
cells and the lysate incubated with the IN-HATw and IN-HATm
recombinant proteins. Flag immunoprecipitates were then
analyzed by western blot. As shown in Figure 2A (upper left
panel), higher amounts of IN-HATw bind KAP1 as compared to
IN-HATm. The same experiment was performed using IN iso-
lated from the HATw or HATm domains following proteolytic
cleavage of the recombinant chimera with the TEV protease. In
Figure 2A (upper right panel), a doublet at the same molecular
size of IN was clearly visible with anti-Flag-KAP1 immunocom-
plexes incubated with IN derived from the IN-HATw chimera,
while no bands were detected using IN-HATm. The doublet
observed in the IN-HATw immunoprecipitation is probably due
to degradation of the IN protein during purification procedures,
since similar doublets are also observed in Figure 1B. These486 Cell Host & Microbe 9, 484–495, June 16, 2011 ª2011 Elsevier Indata clearly demonstrate that KAP1 binds preferentially the acet-
ylated IN rather than the nonacetylated protein.
To further analyze the IN/KAP1 interaction in vivo, Flag-tagged
IN was expressed in HEK293T cells, and the amount of com-
plexed endogenous KAP1 was evaluated following anti-Flag
immunoprecipitation. As shown in Figure 2B, using anti-KAP1
antibodiesendogenousKAP1wasdetectedon IN immunoprecip-
itates, while no bands were found in samples expressing the
control Flag. To verify the role of IN-acetylated lysines located in
the carboxyl terminus, the same immunoprecipitation experiment
was performed using a plasmid expressing Flag-IN mutated in
lysines targeted for acetylation (264, 266, and 273) (Cereseto
et al., 2005). Loweramountsof endogenousKAP1boundmutated
IN as compared to wild-type IN (Figure 2B). This observation was
further verified using untagged INw and INm (Figure S2A).
To further prove the role of acetylation in IN binding with KAP1,
both IN-HATw and IN-HATm chimeras were incubated with
in vitro 35S-labeled KAP1. As shown in Figure 2C, IN-HATw binds
KAP1 with higher affinity than IN-HATm. Since acetylated IN
lysines enhanced the associationwith KAP1, we then specifically
analyzed the role of the IN carboxy domain, which contains the
acetylable lysines (264, 266, and 273). To this aim, pull-down
experiments were performed by incubating recombinant IN
domains fused to glutathione S-transferase (GST) with in vitro
35S-labeled KAP1. KAP1 was found to bind the GST-C terminus
IN at the same extent (10% of the input) of the GST-full-length
IN, while no interaction was observed between KAP1 and either
the N terminus or the catalytic domain (Figure 2D).c.
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and IN/KAP1 complex formation, which is favored by IN acetyla-
tion, occurs through the C-terminal domain of IN.
KAP1 Inhibits HIV-1 Integration
To evaluate the role of KAP1 during HIV-1 infection, this factor
was knocked down in HeLa cells by either transient siRNA treat-
ment or stable shRNA (Figure 3A).Western blot analysis revealed
that the expression of KAP1 was lowered in cells treated with
a pool of siRNA directed against KAP1, as compared to cells
untreated or transfected with control siRNA (Figure 3A, left
panel). Similarly, HeLa cell clones stably expressing KAP1
shRNA (sh-1-KAP1) through a lentiviral vector (GIP-Z) showed
reduced expression of KAP1 as compared to cell clones stably
expressing mismatched shRNA (Figure 3A, right panel). Single-
round infectivity experiments with a VSV-G-pseudotyped HIV-1
clone carrying the luciferase gene as reporter (NL4.3-Luc)
showed that cells in which KAP1 was knocked down were
substantially more sensitive to infection (Figure S3A).
Since KAP1 was reported to possess transcriptional core-
pressor activity and to limit M-MLV infectivity by blocking viral
transcription, we first tested its possible involvement in viral
events other than those regulated by IN. For this purpose, exper-
iments were carried out using the HIV-1 IN (D64E) mutant, which
is integration defective yet does express luciferase from its
circular unintegrated forms. These infections showed no varia-
tion of luciferase activity in KAP1 knockdown cells, indicating
that KAP1 does not affect replication steps unrelated to IN
activity, including viral transcription (Figure S4A). This conclusion
is further sustained by the lack of the regulation of transcriptional
activity reported from a HIV-1 clone transiently transfected in
KAP1 knockdown HeLa cells, as well as from a stably integrated
HIV-1-based viral vector carried in Jurkat T cells (J-lat A1)
(Figures S4B and S4C).
These results strongly suggest that KAP1 regulates viral infec-
tivity during the early events of viral replication, before transcrip-
tion. We therefore sought to quantify, by real-time quantitative
PCR (qPCR), the different DNA viral forms characterizing the
HIV-1 replication cycle (late reverse transcription products,
unintegrated 2-LTRs circles and integrated DNA) in KAP1 knock-
down cells infected with HIV-1. No significant variations (p >
0.05) were observed in cDNA synthesis (late reverse transcripts)
(Figure 3B), implying that KAP1 has no observable effect on
reverse transcription. In contrast, quantification of the 2-LTR
circles showed that these unintegrated forms were significantly
less abundant in KAP1 knockdown cells (Figure 3C). 2-LTR
circles are molecules of circularized retroviral cDNA that fail to
integrate. These viral DNA forms directly correlate with cDNA
nuclear translocation, while they are inversely correlated with
the efficiency of integration. Finally, consistent with the luciferase
activity results (Figure S3A), 8- and 2-fold (p < 0.05) increases
were observed in integrated viral DNA using, respectively, siRNA
or shRNA, against KAP1 (Figure 3D).
Additionally, to verify that the observations so far reported are
not cell type dependent, the same experiments were also repro-
duced in a different cell line (HEK293T) (Figures S3D–S3H).
To verify also that inhibition of viral integration is determined by
specific downregulation of KAP1, the integrated viral DNA was
measured in KAP1 knockdown cells in which the KAP1 expres-Cell Hsion was re-established by using a KAP1 cDNA resistant to
shRNA (sh30KAP1). In these cells, viral integration returned to
baseline, demonstrating specific activity of the KAP1 shRNA
(Figure 3E). Taken together, the increase in the levels of inte-
grated viral DNA and the decrease in 2-LTR circles in the KAP1
knockdown cells support the conclusion that KAP1 negatively
regulates viral integration.
Since KAP1 has been shown to restrict infectivity of M-MLV in
ECSs by inhibiting viral transcription, we tested whether M-MLV
might also be affected by KAP1 at the integration step. To
discern the integration from the transcription step, these exper-
iments were performed by using a M-MLV vector carrying
a CMV-driven luciferase gene. As shown in Figures S4E–S4H,
M-MLV infectivity is not affected in KAP1 HeLa knockdown cells
correlating with no specific effect at the integration step.
To further verify the activity of KAP1 on viral integration, exper-
iments were performed by infecting cells overexpressing KAP1.
Consistently with KAP1 knockdown experiments, high levels of
KAP1 (Figure 3F, left panel) inhibit HIV-1 infection as measured
by luciferase activity (Figure S3B). Notably, decreased infectivity
correlates with significantly reduced levels of integrated viral
DNA (p < 0.05), while reverse transcription products are not
significantly altered (Figure 3F, middle and right panels).
In conclusion, these results demonstrate that KAP1 decreases
viral infectivity by specifically downregulating the efficiency of
the integration event.
KAP1 Inhibits HIV-1 Integration via IN Acetylation-
Dependent Mechanism in Lymphocytic Cells
To specifically test the role of IN acetylation in KAP1-dependent
viral inhibition, we exploited a viral clone (pNL4.3-Luc-3mut)
carrying IN mutated in the lysines targeted for acetylation
(K264, 266, 273R). As previously shown, this virus was less infec-
tious than the parental NL4.3-Luc (Figure 4A and Figure S3C).
However, as observed above (Figure 3D), while the wild-type
virus showed increased proviral DNA formation in KAP1 knock-
down HeLa cells, the integration of the mutated virus was not
significantly altered (p > 0.05) in cells expressing low levels of
KAP1 (Figure 4A and Figure S3C). Therefore these data further
demonstrate that IN acetylation is necessary for KAP1-mediated
inhibition of viral integration.
To test the role of KAP1 in cells naturally targeted by
HIV-1, similar experiments were performed in primary blood
lymphocytes (PBLs) purified from four healthy donors and in a
T cell line (CEMss). PBLs knocked down for KAP1 by electropo-
rated siRNAs (Figure 4B, left panel) showed almost 3-fold
(p < 0.05) increased viral integration following infection with
NL4.3-Luc; however, viral integration remained unaltered in
KAP1 knockdown cells infected with NL4.3-Luc-3mut (Fig-
ure 4B). Similar results were observed in CEMss cells knocked
down by either a cocktail of five KAP1 shRNAs (sh-5-KAP1) or
by a single shRNA contained in the cocktail (sh-30KAP1) (Fig-
ure 4C). The specificity of KAP1-mediated viral inhibition was
further proven by the lack of enhancement of viral integration
observed in KAP1 knockdown CEMss cells (sh-30KAP1) ex-
pressing a nontargetable KAP1 cDNA (Figure 4C, right panel,
fourth column). In these experiments, the levels of total viral
DNA were checked, showing no significant variations (data not
shown).ost & Microbe 9, 484–495, June 16, 2011 ª2011 Elsevier Inc. 487
Figure 3. KAP1 Inhibits HIV-1 Integration
(A) (Left panel) Expression of KAP1 in HeLa cells transiently knocked down with smart pool siRNAs (si-KAP1) and in control HeLa cells treated with a pool of
nontargeting siRNAs (si-CTR). (Right panel) Expression of KAP1 in HeLa cell clones (H14a, H18, and H19) stably knocked down with shRNA expressed by
a lentiviral vector (sh-1-KAP1) and in control HeLa cells expressing a mismatched sh-1-KAP1 (shMM).
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Figure 4. KAP1 Inhibition of HIV-1 Integration Depends on Integrase Lysines Targeted for Acetylation by p300 and Occurs in HIV-1 Natural
Target Cells
(A) KAP1 knockdown (H14a andH18) and control (shMM) HeLa cell clones were infectedwith NL4.3-Luc or NL4.3-Luc-3mut and analyzed by qPCR for integrated
HIV-1 DNA (15 dpi).
(B) Primary T cells (PBLs) transiently knocked down for KAP1 (si-KAP1) and control treated (si-CTR) were infected with NL4.3-Luc or NL4.3-Luc-3mut HIV-1 and
analyzed for integrated HIV-1 DNA (Alu-LTR, 48 hpi). Protein expression was verified by immunoblot.
(C) Integrated NL4.3-Luc HIV-1 or NL4.3-Luc-3mut HIV-1 DNA following infection (15 dpi) of CEMss cells KAP1 knockdown (sh-5-KAP1) and control treated
(GIPZ) and integrated NL4.3-Luc HIV-1following infection (15 dpi) of CEMss KAP1 knockdown (sh-30KAP1) and back-complemented (sh30KAP1 + HA-KAP1).
Protein expression was verified by immunoblot.
All graphs are represented in fold increase with respect to control cells (error bars represent standard deviations from at least two independent experiments).
qPCR absolute values are reported in Table S1. See also Figure S3C.
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ylation in KAP1 viral inhibition in different cell types.
KAP1 Interaction Decreases IN Acetylation through
HDAC1
Results reported in this study so far demonstrate that KAP1 inhi-
bition of viral infectivity is mediated by the interaction of the
cellular protein with acetylated IN. Therefore, in the attempt(B–D) Transient and stable KAP1 knockdown HeLa cells were infected with NL4.3
infection (hpi) (B), 2-LTR DNA circles 24 hpi (C), and integrated HIV-1 DNA 48 hp
(E) Integrated NL4.3-Luc HIV-1 DNA following infection (15 dpi) of HeLa cells KA
control treated (GIPZ). Expression of KAP1 was verified by immunoblot.
(F) Expression of KAP1 in HEK293T cells transfected with KAP1 (pcDNA-KAP1), e
cells (pcDNA-KAP1) and control cells (pcDNA) were infected with NL4.3-Luc HIV-1
and late reverse transcripts (right panel) at 48 hpi.
All graphs are represented in fold increase with respect to control cells (error ba
qPCR absolute values are reported in Table S1. See also Figures S3 and S4.
Cell Hto delineate the molecular mechanism of this phenomena, the
IN acetylation was analyzed relative to KAP1 expression. To
this aim, IN was expressed in HEK293T cells together with
KAP1 and the acetylation levels evaluated using antibodies
against acetylated IN. The overexpression of KAP1 significantly
decreased the acetylation of IN as compared to IN expressed
in the absence of exogenous KAP1 (Figure 5A, upper panel).
The level of IN acetylation was then analyzed in HeLa cell clones-Luc HIV-1 virus and analyzed by qPCR for late reverse transcripts 24 hr post
i (siRNA treated cells) or 15 days postinfection (dpi) (sh-1-KAP1) (D).
P1 knockdown (sh-30KAP1), back-complemented (sh-30KAP1 + HA-KAP1) or
mpty vector (pcDNA), or untransfected (UT) (left panel). Overexpressing KAP1
virus and analyzed by qPCR for integrated HIV-1 DNA (Alu-LTR) (middle panel)
rs represent standard deviations from at least two independent experiments).
ost & Microbe 9, 484–495, June 16, 2011 ª2011 Elsevier Inc. 489
Figure 5. KAP1 Decreases HIV-1 IN Acetylation by Inducing IN/HDAC1 Complex Formation
(A) Flag-IN expressed in HEK293Twith or without exogenous KAP1 (pcDNA-KAP1), immunoprecipitatedwith aFlag antibodies and blottedwith anti-acetylated IN
specific antibodies (aAcIN) to determine IN acetylation levels. Expression of KAP1 and total IN was determined by immunoblot using aKAP1 and aIN antibodies,
respectively.
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Uncovering the Role of Integrase Acetylationstably knocked down for KAP1 (Figure 3A). Transfection of
Flag-IN in KAP1-silenced HeLa cells revealed that the levels of
IN acetylation were substantially increased (Figure 5B, upper
panel). Since HDACs are responsible for protein deacetylation,
we verified the activity of these enzymes on IN. We observed
that HDAC activity is associated with IN (Figure S5A) and that tri-
chostatin A (TSA), a potent inhibitor of these enzymes, increases
the acetylation levels of IN (Figure S5B). Moreover, HDAC1 puri-
fied from HEK293T cells, but not the catalytically inactive form
(H141A) (Hassig et al., 1998), lowered the acetylation levels of
recombinant IN, thus demonstrating that HDAC1 specifically
regulates the acetylation of IN (Figure S5C).
Interestingly, KAP1 has been reported to form complexes with
HDACs determining the deacetylation of its binding partners
(Tian et al., 2009; Tsuruma et al., 2008; Wang et al., 2005;
Wang et al., 2007). We thus sought to investigate whether IN
deacetylation induced by KAP1 would be mediated by complex
formation with HDACs.
Coimmunoprecipitation experiments of Flag-HDAC1 and
Flag-HDAC3 coexpressed with HA-IN showed higher amounts
of IN associated with HDAC1 than with HDAC3. In addition, the
same membrane blotted with anti-KAP1 antibodies revealed
endogenous KAP1 together with the HDAC1 complex and not
with HDAC3 (Figure 5C, second panel from top). These data
thus suggest that IN forms a complex with HDAC1 and KAP1.
To explore the hypothesis that the association of IN with
HDAC1 is mediated by KAP1, the binding of HDAC1 with IN
was checked in HEK293T cells overexpressing KAP1. Immuno-
precipitation of HDAC1 revealed much higher associated IN in
cells overexpressing KAP1 as compared to control cells (Fig-
ure 5D and Figure S2B). These results strongly suggest that
KAP1 plays a role in IN/HDAC1 complex formation. To further
prove this hypothesis, KAP1 knockdown cells were transfected
with both HA-IN and Flag-HDAC1, and HDAC1 immunoprecipi-
tates were verified for the amounts of associated IN.When KAP1
expression was downregulated, the levels of IN complexed with
HDAC1 were strikingly lower than control cells expressing mis-
matched KAP1 shRNA (Figure 5E, upper panel).
In conclusion, these data clearly demonstrate that KAP1
induces IN deacetylation by favoring HDAC1 binding to IN.
KAP1 Inhibits HIV-1 Integration through HDAC1
Results reported here indicate that KAP1 lowers IN acetylation
through HDAC1 tethering. Since our previous reports demon-
strate that acetylation of IN positively regulates viral integration
(Cereseto et al., 2005; Terreni et al., 2010), we assumed that
HDAC1 deacetylase activity might downregulate HIV-1 integra-
tion. To verify this hypothesis, we analyzed viral integration in
cells treated with HDAC inhibitors. Infection of cells treated
with TSA or with a specific inhibitor of HDAC1, MS-275 (Nish-(B) Flag-IN expressed in either HeLa cell clones stably knocked down for KAP1
precipitated with aFlag antibodies and blotted with aAcIN antibodies. Total IN w
(C) HA-IN was coexpressed with either Flag-HDAC1 or Flag-HDAC3 in HEK293T
(HDAC1 and HDAC3) antibodies. Total IN was detected by aHA immunoblot.
(D) HA-IN and Flag-HDAC1 were coexpressed in HEK293T cells with or withou
blotted with aHA (IN) antibodies. The expression levels of KAP1, HDAC1, and IN
(E) HA-IN and Flag-HDAC1 were coexpressed in KAP1 stably knocked down c
immunoprecipitates were blotted with aHA (IN) antibodies. Expression levels of
See also Figures S2A and S5.
Cell Hioka et al., 2008), determined an increase of viral integration
(as shown in Figure 6A), while total viral DNA remained unal-
tered (data not shown). To better pinpoint the role of HDAC1
in viral integration, infections were then performed in HDAC1
knockdown cells (Figure 6B, left panel). We observed that in
conditions of low HDAC1 expression the integration (Alu-LTR)
was increased by almost 4-fold, while the unintegrated 2-LTR
circles were decreased by 2-fold (Figure 6B, middle and right
panels). To verify that HDAC1 affects specifically the integra-
tion reaction, the total viral DNA was also quantified, showing
no major alteration in cells silenced for HDAC1 (data not
shown).
Since results reported so far strongly suggest that KAP1 inhi-
bition of viral integration might occur through HDAC1 deacety-
lase activity, we sought to analyze the interplay between these
factors during HIV-1 integration. To this aim, infections were per-
formed in cells in which the expression of both HDAC1 and KAP1
was simultaneously modulated by silencing (HDAC1) and over-
expression (KAP1) (Figure 6C, left panel). In agreement with
results reported in Figure 3F, integration of viral cDNA was
substantially reduced in cells overexpressing KAP1 (Figure 6C,
right panel), while the amounts of the late reverse transcripts
remained unaltered (data not shown). In cells that were silenced
for HDAC1, however, overexpression of KAP1 did not show any
viral inhibitory effect (Figure 6C, right panel). These experiments
were also performed in HDAC3 knockdown cells, where no
significant modulation of viral integration was observed (Fig-
ure S6), consistently with the weak association of this enzyme
with IN and the absence of KAP1 in the IN-HDAC3 complex (Fig-
ure 5C). Therefore, these data clearly demonstrate that KAP1
integration-specific inhibitory effects occur through HDAC1
activity. The role of HDAC1 in KAP1 inhibitory effects was further
sustained by the results showing that the KAP1 N-terminal
domain (1–381) involved in viral inhibition correlates with HDAC1
binding properties, while the inactive KAP1 C-terminal domain
(617–835) was not able to bind HDAC1 (Figure S6).
Collectively, these data clearly show that KAP1 inhibits viral
integration by recruiting HDAC1 to IN leading to deacetylation
of the viral protein.
DISCUSSION
Acetylation of HIV-1 IN enhances viral integration (Cereseto
et al., 2005; Terreni et al., 2010). The role of this modification
during the viral life cycle is proven by the decreased infectivity
and provirus formation following inhibition of IN acetylation
(Apolonia et al., 2007; Cereseto et al., 2005; Terreni et al.,
2010; Topper et al., 2007).
Posttranslational modifications, such as acetylation, regulate
protein functions by modifying protein-protein interactions.by sh-1-KAP1 (H14a, H18, and H19) or in control cells (sh-MM) was immuno-
as detected by reprobing with aFlag antibodies.
cells. aFlag immunoprecipitates were blotted with aHA (IN), aKAP1, and aFlag
t exogenous KAP1 (pcDNA-KAP1). aFlag (HDAC1) immunoprecipitates were
were controlled by immunoblot using the indicated antibodies.
ell clones (H14a, H18, and H19) and in control cells (sh-MM). aFlag (HDAC1)
IN and HDAC1 were controlled by immunoblot using the indicated antibodies.









Figure 6. KAP1 Inhibition of HIV-1 Integration Is Mediated by HDAC1
(A) HeLa cells treated with 600 nMMS-275 or with 800 nM TSA were infected with NL4.3-Luc HIV-1 and analyzed by qPCR for integrated HIV-1 DNA (Alu-LTR) at
24 hpi.
(B) Expression of HDAC1 in HeLa cells transiently knocked down with smart pool siRNA (si-HDAC1) and in control HeLa cells treated with a pool of nontargeting
siRNA (si-CTR) (left panel). HeLa cells transiently knocked down for HDAC1 were infected with NL4.3-Luc HIV-1 and analyzed by qPCR for integrated HIV-1 DNA
(Alu-LTR) at 48 hpi (middle panel) and 2-LTR DNA circles at 24 hpi (right panel).
(C) Expression of KAP1 and HDAC1 in HEK293T cells transfected with pcDNA-KAP1 and transiently knocked down with si-HDAC1 (left panel). HEK293T cells
overexpressing KAP1 (pcDNA-KAP1) were cotreated or not with si-HDAC1, subsequently infected with NL4.3Luc HIV-1, and analyzed by qPCR for integrated
HIV-1 DNA (Alu-LTR) at 48 hpi (right panel).
All graphs are represented in fold increase with respect to control cells (error bars represent standard deviations from at least two independent experiments).
qPCR absolute values are reported in Table S1. See also Figure S6.
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Uncovering the Role of Integrase AcetylationSince HIV-1 IN is functionally regulated by the association with
cellular cofactors, we hypothesized that acetylationmightmodu-
late the association of IN with known or still-unidentified cellular
factors. To this aim we have carried out a modified two-hybrid
screening that differs from all screening so far performed for
using as ‘‘bait’’ an IN constitutively acetylated through its fusion
with the HAT domain of p300 (Allouch and Cereseto, 2009). This
screening revealed that KAP1 interacts with acetylated IN and
with a lower affinity to the unmodified form. Investigation on
the role of KAP1 during the viral replication cycle showed that
KAP1 downregulation enhances viral infectivity due to a specific
increase in viral integration. This observation has been further
confirmed by reciprocal experiments showing that KAP1 overex-
pression reduces provirus formation. Cellular antiretroviral
defense blocks viral infectivity at specific time points during
the viral replication cycle. In addition to the well-defined restric-
tion factors, a growing number of host cellular genes have
been described to reduce susceptibility to retrovirus infection
(Boulanger et al., 2005; Ganesh et al., 2003; Naghavi et al.,
2005, 2007; Turelli et al., 2001). Among the factors so far identi-
fied, only one, p21Cip1, has been described to decrease infec-
tivity by interfering with viral integration (Zhang et al., 2005,
2007). Since p21Cip1 is a cell cycle checkpoint protein playing
a role in DNA damage response, it has been speculated that
DNA damage pathways activated by the virus are responsible492 Cell Host & Microbe 9, 484–495, June 16, 2011 ª2011 Elsevier Infor p21Cip1 antiviral activity; however, the molecular mechanism
underlying viral integration inhibition has not been delineated
(Zhang et al., 2007). Here we demonstrate that KAP1 inhibits viral
infectivity by specifically interfering with viral integration. By
binding to the acetylated IN, KAP1 induces HDAC1 complex
formation, leading to IN deacetylation and reduced integration
efficiency. We have proven that HDAC1 is essential for KAP1-
mediated viral inhibition, since overexpression of KAP1 does
not reduce integration in cells silenced for HDAC1. Conversely,
HDAC3which is not part of the IN/KAP1 complex does not affect
the inhibitory activity of KAP1. The HDAC1-KAP1 interplay in
HIV-1 inhibition is further sustained by the demonstration that
the efficacy of the truncated KAP1 domains on HIV-1 replication
correlates with their binding properties with HDAC1 (see Fig-
ure S6 for further discussion). Interestingly, recently it has been
reported that HDAC1 affects HIV-1 reverse transcription (Sorin
et al., 2009). However, our data show a specific involvement of
this enzyme during the integration event and not during reverse
transcription. These apparent discrepancies could be explained
by the fact that Sorin et al. (2009) analyze HDAC1 interacting with
nascent viral particles, while in this study HDAC1 is analyzed in
postentry steps.
Emerging evidence indicates that KAP1 is involved in acety-
lation/deacetylation activities unrelated to transcriptional con-
trol. In fact, KAP1 has recently been shown to inactivatec.
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Uncovering the Role of Integrase Acetylationproteins involved in DNA damage response (p53 and E2F1) by
deacetylating these proteins through HDACs tethering (Tian
et al., 2009; Wang et al., 2005, 2007). Notably, it has been sug-
gested that unintegrated HIV-1 cDNA is substrate for DNA
double-strand break repair factors, which in turn activate
DNA damage response (Daniel et al., 1999; Jeanson et al.,
2002; Kilzer et al., 2003; Li et al., 2001; Lloyd et al., 2006).
Moreover, ATM that predominantly detects DNA double strand
breaks has been demonstrated to be activated following HIV-1
infection, and its inhibition through a small molecule (KU-55933)
drastically decreases cellular susceptibility to viral infection
(Lau et al., 2005; Perfettini et al., 2008). Since KAP1 is ubiqui-
tously expressed showing no major restriction of HIV-1 infec-
tivity, we propose a model whereby ATM activated by uninte-
grated HIV-1 phosphorylates KAP1, leading to disassembly of
the IN/HDAC1 complex. This would ultimately reverse HDAC1
deacetylase activity associated to IN, thus allowing the recon-
stitution of IN acetylation and restored levels of integration effi-
ciency. Very similar results have been reported to regulate p53
activity through an acetylation/deacteylation cycle regulated by
KAP1 (Tian et al., 2009). In fact, this study shows that in
unstressed cells p53 is inactivated by deacetylation through
KAP1-mediated HDAC1 binding. In response to DNA damage,
ATM rapidly activates p53 through phosphorylation of KAP1,
leading to p53/HDAC1 complex disruption and p53 acetylation.
Further studies are required to verify a similar model for IN
regulation.
KAP1 has also been described to restrict M-MLV in embryonic
carcinoma and ESCs. However, in that case viral inhibition
occurs at the level of transcription specifically in ECSs, while
here we show that integration of theM-MLV cDNA is not affected
by KAP1. In ESCs infected with M-MLV, KAP1 is part of a large
protein complex that binds the proviral primer binding site
(PBS) leading to transcriptional repression (Wolf and Goff,
2007, 2009; Wolf et al., 2008). KAP1-mediated inhibition of viral
transcription appears to be shared among retroviruses contain-
ing PBS sequences complementary to tRNAPro such as M-MLV
and HTLV-1, or tRNALys-1,2 such as visna, spuma, and Mason-
Pfeizer monkey virus (Wolf and Goff, 2009; Wolf et al., 2008).
Conversely, the HIV-1 PBS does not contain either tRNAPro or
tRNALys-1,2 complementary sequences, and is thus not suscep-
tible to KAP-1-mediated transcriptional repression, as also
confirmed by our results. Interestingly, the KAP1 inhibitory
activity on transcription is responsible for controlling endogenous
retroelements during early embryonic development (Rowe et al.,
2010), suggesting a potential role of KAP1 in HIV-1 postintegra-
tion latency. However, we observed that KAP1 is expressed
at the same levels in cells harboring silent or activated provirus
as well as in the main cell types involved in HIV-1 latency (Fig-
ure S4D). Hence, these data, together with the absence of
KAP1 in transcriptional repression suggested by other reports
(Wolf and Goff, 2009; Wolf et al., 2008), disfavor a hypothetical
role of KAP1 in postintegration latency.
The different molecular mechanism of KAP1 restriction might
parallel the dual activities of this factor at the cellular level: tran-
scriptional as a corepressor and protein activity regulator
through acetylation.
In summary, our study demonstrates that KAP1 inhibits HIV-1
integration through a cellular pathway targeting acetylated IN.Cell HEXPERIMENTAL PROCEDURES
The vectors, constructs, antibodies, transient/stable knockdowns, and back-
complementation are described in detail in the Supplemental Experimental
Procedures.Yeast Two-Hybrid Screen
A human T-lymphocytes cDNA library fused to Gal4 activating domain in
a pACT vector (BD Biosciences Clontech, Palo Alto, CA) was expressed in
AH109 yeast cells and screened with the pGBD-IN-HATw (bait) expression
vector. Library transformation and screening were performed following the
manufacturer’s instructions (Matchmaker GAL4 Two-Hybrid System 3).
GAD-KAP1 was coexpressed in AH109 yeast cells with GDBD fused to IN-
HATw/m, HATw/m, and IN to check for interactions.IN-HATw and IN-HATm Purification and TEV Digestion
pASK-IN-HATw/m encoding for 6xHis-IN-HATw/m was transformed in E. coli
Arctic Express RIL competent cells (Stratagene), and induction of protein
expression was performed using 43 mM anhydrotetracycline hydrochloride
(AHT) for 24 hr at 13C. Bacteria culture was lysed in binding buffer (1 M
NaCl, 20 mM Tris HCl [pH 7.9], and 0.5% Triton X-100). 6xHis-IN-HATw/m
was purified using TALON Metal Affinity Resin (BD Biosciences). For TEV
digestion, 20 mg of 6xHis-IN-HATw/m was incubated with 30 units of AcTEV
protease (Invitrogen, Paisley, UK) in 120 mM NaCl, 50 mM Tris-HCl (pH 8),
0.5 mM EDTA, and 1 mM DTT in 250 ml total volume. 6xHis-IN TEV-digested
products were adjusted to 1 M NaCl and recovered using Ni-NTA agarose
resin (QIAGEN, Hilden, Germany).Virus Productions and Infections
NL4.3-Luc and NL4.3-Luc-3mut viruses pseudotyped with the Vesicular
Stomatitis Virus-G (VSV-G) envelope were produced by transfecting 5 3 106
HEK293T cells with 20 mg pNL4.3.Luc.R-E- or pNL4.3-Luc-3mut and 5 mg
p-MDG-VSV-G using 150 nM polyethylenimine (PEI) reagent (Sigma, St. Louis,
MO). Viral supernatants were collected 48 hr posttransfection, quantified
for their HIV-1 p24 antigen content using Innotest HIV Antigen mAb kit
(INNOGENETICS N.V., Gent, Belgium), and DNase I treated before infection
(40 U/ml) (TURBO DNase-Applied Biosystems, Foster City, CA).
Infections of transiently knocked down cells were performed for 2 hr using
the following: 100 ng p24 for 63 105 HeLa cells 48 hr after siRNA transfection,
250 ng p24 for 53 105 CEMss cells 60 hr posttransduction with KAP1 shRNAs
lentiviral vectors, and 500 ng p24 for 23 105 PBLs 24 hr after siRNA transfec-
tion. For back-complementation experiments, HeLa or CEMss cells were
infected 60 hr post-LKO.1-sh-30KAP1 and AIP-HA-KAP1 (1–835) transduc-
tions using 250 ng p24 NL4.3-Luc (VSV-G) HIV-1 virus for 53 105 cells. Infec-
tions of stable knockdown HeLa cell clones (3 3 105) were performed using
300–1200 ng p24. Infections of HEK293T cells transfected 24 hr in advance
with pcDNA3-KAP1 (6.25 mg for 1.23 106 cells with PEI) were performed using
125 ng p24 for 2.5 3 105 cells.Real-Time Quantitative PCR
Integrated HIV-1 copies by Alu-LTR and two LTRs circles were analyzed by
qPCR as previously described (Brussel and Sonigo, 2003). Total viral DNA
was analyzed as previously described (Butler et al., 2001). Total and integrated
HIV-1 DNA quantifications in cells carrying GIPZ, LKO.1, or AIP lentiviral DNAs
were performed by using primers/probes specific for the luciferase gene in
NL4.3-Luc 24 hr or 15 days postinfection, respectively, to avoid crossreactivity
between viral LTR (Terreni et al., 2010). MLV late reverse transcripts and
integrated MLV DNA at 24 hr and 15 days postinfection, respectively, were
quantified using primers/probes specific to the luciferase gene that recognize
LNC-CMV-eGFPT2A-fLuc MLV viral vector (Terreni et al., 2010). A kinetic PCR
assay for human b-globin DNA was carried out as endogenous control as
previously described (Tan et al., 2006). The fold increase/decrease ratios of
the real-time data were calculated using the mathematical model for the rela-
tive quantification in the real-time PCR (Pfaffl, 2001) where the HIV-1 gene is
the ‘‘target gene’’ and b-globin gene is the ‘‘reference gene.’’ost & Microbe 9, 484–495, June 16, 2011 ª2011 Elsevier Inc. 493
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Uncovering the Role of Integrase AcetylationImmunoprecipitations and Flag-KAP1 Pull-Downs
GBD-IN-HATw/m expression and immunoprecipitations in yeast cells were
performed as previously described (Guo et al., 2004) with minor modifications.
For Flag immunoprecipitation experiments, HEK293T or HeLa cells expressing
Flag-tagged proteins were lysed in NEHN buffer (300mMNaCl, 50mMHEPES
[pH 7.5], 0.5% NP-40, 20% glycerol, and 1 mM EDTA). Lysates (500–2000 mg)
were incubated with 30 ml anti-Flag M2 agarose beads (Sigma) followed by
western blot analysis. KAP1 binding to Flag-INw/m was performed using
transfected cells treated with 1 mM TSA for 8 hr.
For Flag pull-down experiments, HEK293T expressing Flag-KAP1 was lysed
in 50 mM HEPES (pH 7.4), 150 mM NaCl, and 0.5% NP-40. Lysates (250 mg)
containing a HAT inhibitor (Lys-CoA) were incubated with 250 ng of either
6xHis-IN-HATw/m or 6xHis-IN TEV-digested products and pulled down by
anti-Flag M2 agarose beads (Sigma) followed by western blot analysis.In Vitro Binding Assays
In vitro-translated 35S-KAP1 was produced using TNT T7 Reticulocyte Lysate
System (Promega) and pcDNA3-KAP-1 as template. GST-IN full-length and
GST-IN truncated domains (N terminus, core, and C terminus) preparations
and in vitro binding have been previously described (Cereseto et al., 2005).
In vitro binding between 6xHis-IN-HATw or 6xHis-IN-HATm and 35S-KAP1
was performed by incubating 1000 ng of either recombinant purified proteins
with 1000 cpm of 35S-KAP-1, 20 mg BSA, and 15 ml of Ni-NTA agarose (settled
beads volume) in 1000 ml pull-down buffer (150mMNaCl, 2mMMgCl2, 25mM
imidazole, 0.1%NP-40, 25mM imidazole, and 50mMTris-HCl [pH 7.4]) for 5 hr
at 4C. Following three washes in pull-down buffer, the reaction mixture was
separated by SDS-PAGE gel analyzed by phosphoimaging (Cyclone).Statistical Analysis
Statistical significance of the results obtained in the HIV-1 infectivity assays
was assessed by the two-tailed Student’s t test, assuming equal variance
between samples to determine differences at the 5% level of significance.SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, one table, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article online at doi:10.1016/j.chom.2011.05.004.ACKNOWLEDGMENTS
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